| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |